Previous studies reported that the frequency of NTRK fusions ranges from 0.1 to 3.3% in NSCLC patients worldwide, with fusions in NTRK1 and NTRK3 being more common than NTRK27,10,15,20–27. This evidence concerns the gene NTRK3 and non-small cell lung carcinoma.